N-ACETYL-DE-O-SULFATED HEPARIN SODIUM SALT(CAS: 133686-69-8)

N-ACETYL-DE-O-SULFATED HEPARIN SODIUM SALT (CAS: 133686-69-8) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. Manufacturers must comply with GHS for classification and labeling, REACH for registration, evaluation, and authorization of substances, and FDA/EPA for safety and environmental standards.

There are alternatives to N-ACETYL-DE-O-SULFATED HEPARIN SODIUM SALT (CAS: 133686-69-8) in synthesis, such as other modified heparins or synthetic analogs. Common alternative reagents include acetylated heparin derivatives and oligosaccharides, which can serve similar functions in various applications.

The market for N-ACETYL-DE-O-SULFATED HEPARIN SODIUM SALT (CAS: 133686-69-8) is driven by its applications in biomedical research and pharmaceuticals. Research trends indicate a growing interest in modified heparins for drug delivery systems and as anticoagulants. Market dynamics show increasing demand, particularly in Europe and the United States, due to ongoing clinical trials and regulatory approvals.

Waste containing N-ACETYL-DE-O-SULFATED HEPARIN SODIUM SALT (CAS: 133686-69-8) should be handled by collecting it in appropriate containers, ensuring proper labeling, and disposing of it through professional waste disposal services. Environmental protection measures include minimizing contamination and following local regulations for hazardous waste management. Incineration is a common method, but other safe disposal options are available based on local guidelines.